INTERNATIONAL PATENT: ASCENEURON SA FILES APPLICATION FOR "(2-(4-(1-(BENZO[D]THIAZOL-5-YL)ETHYL)PIPERAZIN-1 -YL)PYRIMIDIN-5-YL)(IMINO)(METHYL)-LAMDA6-SULFANONE FOR USE IN THE TREATMENT OF COLITIS, PARKINSON DISEASE, TAUOPATHY, ALS AND ALZHEIMER'S DISEASE"

GENEVA, June 30 -- ASCENEURON SA (EPFL Innovation Park, Batiment B1015 Lausanne) filed a patent application (PCT/EP2023/087104) for "(2-(4-(1-(BENZO[D]THIAZOL-5-YL)ETHYL)PIPERAZIN-1 -YL)PYRIMIDIN-5-YL)(IMINO)(METHYL)-LAMDA6-SULFANONE FOR USE IN THE TREATMENT OF COLITIS, PARKINSON DISEASE, TAUOPATHY, ALS AND ALZHEIMER'S DISEASE" on Dec 20, 2023. With publication no. WO/2025/131275, the details related to the patent application was published on Jun 26, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): BEHER, Dirk (Residences du Golf A41196 Gland), PERMANNE, Bruno (118 route de Dingy74520 Dingy-e...